2022
DOI: 10.3390/microorganisms10061103
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Escherichia coli: From Biofilm Formation to New Antibiofilm Strategies

Abstract: Escherichia coli is one of the species most frequently involved in biofilm-related diseases, being especially important in urinary tract infections, causing relapses or chronic infections. Compared to their planktonic analogues, biofilms confer to the bacteria the capacity to be up to 1000-fold more resistant to antibiotics and to evade the action of the host’s immune system. For this reason, biofilm-related infections are very difficult to treat. To develop new strategies against biofilms, it is important to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
35
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(36 citation statements)
references
References 108 publications
1
35
0
Order By: Relevance
“…The biofilm formation of E. coli occurs in followed phases; reversible attachment, irreversible attachment, maturation, and dispersion [ 48 ]. In particular, the maturation phase is characterized by the final architecture and arrangement of the biofilm conferred by the matrix formation [ 49 ]. The matrix provides biofilm stability, promotes intercellular interaction, and enables the transport of nutrients and waste through the biofilms.…”
Section: Discussionmentioning
confidence: 99%
“…The biofilm formation of E. coli occurs in followed phases; reversible attachment, irreversible attachment, maturation, and dispersion [ 48 ]. In particular, the maturation phase is characterized by the final architecture and arrangement of the biofilm conferred by the matrix formation [ 49 ]. The matrix provides biofilm stability, promotes intercellular interaction, and enables the transport of nutrients and waste through the biofilms.…”
Section: Discussionmentioning
confidence: 99%
“…Studies show that the ability to create a biofilm depends on various factors. One of them is that biofilm formation is genetically encoded and is one of the defense mechanisms that ensure resistance [ 14 , 15 ]. Many studies indicate that the mechanical and physical–chemical properties of the biofilm matrix reduce or delay the penetration of many compounds, including antibacterial agents.…”
Section: Introductionmentioning
confidence: 99%
“…The development of biofilm at a surface results from physical, chemical, and microbial processes, including pH, hydrodynamics, osmolarity, presence of specific ions, nutrients, and factors derived from the biotic environment [ 8 ]. The transition from the planktonic to the biofilm state involves the interaction of several proteins and regulatory systems, such as 3′,5′-cyclic diguanylic acid (c-di-GMP), two-component signaling systems (TCS), the RcsCDB regulator, and quorum sensing (QS) [ 9 ]. Other factors contributing to K. pneumoniae biofilm formation include, among others, the presence of a polysaccharide capsule, lipopolysaccharide (LPS), fimbriae, pili, iron metabolism, and the presence of other bacterial species [ 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…They can survive the presence of disinfectants, shear forces, thermal stress, and predators [ 4 ]. The resistance mechanisms of biofilms include the physical barrier provided by the extracellular matrix, which decreases antimicrobial penetration; alteration of the outer membrane; the production of enzymes that transform biocides into non-toxic forms; persister cells; efflux pumps; high heterogeneity in metabolism and growth rates; horizontal gene transfer [ 9 , 12 ]; and adaptive mutagenesis [ 13 ].…”
Section: Introductionmentioning
confidence: 99%